Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,196 | 23,694 | 23,787 | 19,137 | 57,633 |
| Marketable Securities | 67,338 | 57,539 | 103,639 | 85,629 | 105,357 |
| Receivables | 2,032 | 4,055 | 6,490 | 16,570 | 7,333 |
| TOTAL | $94,201 | $87,815 | $138,362 | $124,597 | $171,851 |
| Non-Current Assets | |||||
| PPE Net | 12,773 | 15,949 | 18,320 | 9,025 | 7,307 |
| Investments And Advances | 6,315 | 9,406 | 11,395 | 19,830 | 19,993 |
| Intangibles | 14,207 | 15,274 | 16,523 | 18,142 | 14,019 |
| Other Non-Current Assets | 16,455 | 2,670 | 2,639 | 2,113 | 671 |
| TOTAL | $49,751 | $43,298 | $48,877 | $49,110 | $41,990 |
| Total Assets | $143,952 | $131,113 | $187,239 | $173,707 | $213,841 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,967 | 24,113 | 24,206 | 20,670 | 13,230 |
| Accrued Expenses | 4,050 | 5,672 | 8,612 | 6,368 | 2,601 |
| Other current liabilities | N/A | N/A | 361 | 1,168 | 1,301 |
| TOTAL | $31,989 | $35,300 | $35,405 | $43,823 | $31,466 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,843 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 6,898 | 5,516 | 2,227 | 15,617 | 14,335 |
| Other Non-Current Liabilities | 94,639 | 87 | 0 | 0 | -85 |
| TOTAL | $106,557 | $8,781 | $9,345 | $6,506 | $6,441 |
| Total Liabilities | $138,547 | $44,081 | $44,751 | $50,329 | $37,908 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,145 | 8,133 | 7,531 | 6,173 | 6,016 |
| Common Shares | 101 | 97 | 90 | 74 | 72 |
| Retained earnings | -739,786 | -620,427 | -523,356 | -434,838 | -361,098 |
| Other shareholders' equity | 2,442 | -433 | -21 | 1,424 | 2,954 |
| TOTAL | $5,405 | $87,032 | $142,489 | $123,378 | $175,933 |
| Total Liabilities And Equity | $143,952 | $131,113 | $187,239 | $173,707 | $213,841 |